E.F. Hutton places $5M public offering for iSpecimen

E.F. Hutton & Co. served as exclusive placement agent for a $5 million public offering by iSpecimen Inc. (Nasdaq: ISPC), according to a press release from the investment bank.

iSpecimen, which operates an online marketplace connecting medical researchers with biospecimen providers, said it plans to use the proceeds to repay outstanding liabilities, fund potential acquisitions and investments, support marketing initiatives, and cover general corporate purposes.

The transaction is the third capital markets engagement between E.F. Hutton and iSpecimen since December 2025.

Joseph T. Rallo, Chief Executive Officer of E.F. Hutton, said: "We are pleased to once again support iSpecimen on another successful financing. This transaction represents our third capital markets engagement with the Company in less than a year, reflecting the strength of our relationship and our shared commitment to supporting innovative healthcare companies as they execute their long-term growth strategies."

E.F. Hutton is a New York-based investment bank and broker-dealer that provides capital markets services to corporations, financial sponsors, and institutional investors.

You May Also Be Interested In

• iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
• Savers Value Village prices $205M secondary stock offering
• Openlane shareholder launches secondary offering of 8M shares